Seppo Ylä‐Herttuala

Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man.

Seppo Ylä‐Herttuala, Wulf Palinski, Michael E. Rosenfeld et al. · Journal of Clinical Investigation · 1989 · 1.9K citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Low density lipoprotein undergoes oxidative modification in vivo.

Wulf Palinski, Michael E. Rosenfeld, Seppo Ylä‐Herttuala et al. · Proceedings of the National Academy of Sciences · 1989 · 1.5K citations · Full text

Life Sciences, Biochemistry, Pathobiology +17

Autoantibody against oxidised LDL and progression of carotid atherosclerosis

J T Salonen, H Korpela, R. Salonen et al. · The Lancet · 1992 · 1.3K citations · Full text

Life Sciences, Biochemistry, Molecular Medicine +11

Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.

Seppo Ylä‐Herttuala, Beth Lipton, Michael E. Rosenfeld et al. · Proceedings of the National Academy of Sciences · 1991 · 877 citations

Life Sciences, Cell Biology, Molecular Biology +11

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

Tuomas Tammela, Georgia Zarkada, Elisabet Wallgard et al. · Nature · 2008 · 811 citations

Medicine, Molecular Biology, Oncology +14